HART MEDICAL PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: A81041 | HARTLEPOOL, TS24 9DN
Showing results 501-550 of 570
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 15 | 1,350 | £136 | -32.9% ▼ | |
| 15 | 720 | £1.8K | -1.5% vs avg | |
| Naftidrofuryl oxalate | 14 | 1,344 | £161 | -57.0% ▼ |
| Dipyridamole | 14 | 840 | £175 | -45.5% ▼ |
| Zolpidem tartrate | 14 | 392 | £16 | -84.5% ▼ |
| Apomorphine hydrochloride hemihydrate | 14 | 71 | £2.1K | +90.7% ▲ |
| Colistimethate sodium | 14 | 840 | £2.6K | +23.8% ▲ |
| Biphasic insulin lispro | 14 | 105 | £619 | -67.4% ▼ |
| Alprostadil | 14 | 56 | £669 | -18.1% ▼ |
| Pdr 3.8 - 4.9 kcal/g energy (carbohyd) fortifier (0913142) | 14 | 2,456 | £172 | +75.8% ▲ |
| Gel OTC glucose for diabetic hypo treatment (0913541) | 14 | 1,081 | £102 | +17.3% ▲ |
| Cyclopentolate hydrochloride | 14 | 70 | £113 | +144.8% ▲ |
| Terbinafine hydrochloride | 14 | 390 | £72 | -62.3% ▼ |
| 14 | 166 | £145 | -56.7% ▼ | |
| 14 | 224 | £966 | +156.5% ▲ | |
| 14 | 273 | £986 | +121.8% ▲ | |
| 14 | 114 | £179 | +75.1% ▲ | |
| 14 | 70 | £181 | -42.2% ▼ | |
| 14 | 153 | £362 | -21.1% ▼ | |
| 14 | 330 | £261 | +31.6% ▲ | |
| 14 | 475 | £51 | +6.1% ▲ | |
| Nizatidine | 13 | 390 | £192 | -62.2% ▼ |
| Rabeprazole sodium | 13 | 364 | £21 | -74.8% ▼ |
| Balsalazide sodium | 13 | 2,184 | £487 | -12.7% ▼ |
| Olmesartan medoxomil | 13 | 728 | £37 | -81.1% ▼ |
| Isosorbide dinitrate | 13 | 1,680 | £366 | -27.7% ▼ |
| Fluvastatin sodium | 13 | 728 | £302 | -43.8% ▼ |
| Hyoscine hydrobromide | 13 | 728 | £116 | -61.9% ▼ |
| Sodium chloride | 13 | 780 | £500 | +55.6% ▲ |
| Tube feed additive 0.5 kcal/ml high fibre liquid (0914052) | 13 | 364 | £387 | +34.8% ▲ |
| Meloxicam | 13 | 364 | £13 | -80.3% ▼ |
| Etoricoxib | 13 | 364 | £49 | -83.9% ▼ |
| Capsaicin | 13 | 585 | £219 | +64.7% ▲ |
| Carbomer 974P | 13 | 140 | £60 | +60.5% ▲ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 13 | 2,205 | £267 | +49.9% ▲ |
| 13 | 185 | £1.6K | -53.3% ▼ | |
| 13 | 1,950 | £573 | +141.0% ▲ | |
| 13 | 370 | £1.5K | +27.6% ▲ | |
| 13 | 260 | £1.5K | +4.1% ▲ | |
| Telmisartan with diuretic | 12 | 672 | £388 | +6.1% ▲ |
| Trifluoperazine | 12 | 336 | £406 | -20.4% ▼ |
| Flupentixol hydrochloride | 12 | 672 | £53 | -63.4% ▼ |
| Urine testing reagents | 12 | 600 | £34 | +7.3% ▲ |
| Medroxyprogesterone acetate | 12 | 906 | £137 | -68.6% ▼ |
| Solifenacin/tamsulosin | 12 | 506 | £444 | -41.6% ▼ |
| Goserelin acetate | 12 | 12 | £2.8K | -72.8% ▼ |
| Xylometazoline hydrochloride | 12 | 120 | £27 | +109.0% ▲ |
| Zinc oxide | 12 | 1,765 | £69 | -40.3% ▼ |
| Tirbanibulin | 12 | 60 | £673 | +91.3% ▲ |
| Other individually formulated bought in preparations | 12 | 418 | £81 | -63.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.